Rich Slim
Mounjaro — Using the strongest GLP-1 safely
Mounjaro (tirzepatide) is the next-generation GLP-1+GIP dual agonist beyond Wegovy. SURMOUNT-5 demonstrated -20.2% weight loss over 72 weeks — the most powerful effect among obesity medications. The stronger the tool, the more important it is to use it well.
Bottom line
Mounjaro is a dual agonist that stimulates both GLP-1 and GIP, producing the strongest weight loss of any single-pathway drug. The stronger the effect, the more important protein intake and resistance training become. ① 1.8–2.2g of protein per kg of body weight, ② resistance training 2–3 times a week, ③ gradual dose titration — these three are the keys to safely enjoying Mounjaro's powerful effect.
Key data
-20.2%
Average weight loss at 72 weeks
SURMOUNT-5, NEJM 2025
+5.3%p
Additional weight loss vs Wegovy
SURMOUNT-5 head-to-head
-22.5%
Highest dose (15mg)
SURMOUNT-1, NEJM 2022
주 1회 피하주사
Administration
용량 단계: 2.5→5→7.5→10→12.5→15mg
2023년(Zepbound)
FDA obesity approval
Eli Lilly · 미국
GLP-1 + GIP 이중
Mechanism
위고비(GLP-1 단일) 대비 추가 작용
22.5%
SURMOUNT-1 Mounjaro 15mg average weight loss (72 weeks)
Jastreboff AM et al. NEJM 2022;387:205
57%
Proportion reaching ≥20% weight loss on Mounjaro
SURMOUNT-1 15mg arm
Mounjaro (tirzepatide) basics
| Item | Details |
|---|---|
| Active ingredient | Tirzepatide |
| Manufacturer | Eli Lilly (USA) |
| Approval | Diabetes (Mounjaro) 2022 / Obesity (Zepbound) 2023 FDA approval |
| Administration | Once-weekly subcutaneous injection (abdomen, thigh, upper arm) |
| Dose steps | 2.5 → 5 → 7.5 → 10 → 12.5 → 15mg (gradual titration over 24 weeks) |
| Mechanism | Dual action on GLP-1 receptor + GIP receptor — appetite suppression + insulin secretion + improved fat metabolism |
| Half-life | About 5 days (allows once-weekly dosing) |
Source: Mounjaro DailyMed · SURMOUNT 임상 시리즈 · Eli Lilly 공식 자료
Wegovy vs Mounjaro — effect comparison
| Item | Wegovy (semaglutide 2.4mg) | Mounjaro (tirzepatide 15mg) |
|---|---|---|
| Weight loss (~72 weeks) | -14.9–17.4% | -20.2–22.5% |
| Mechanism | GLP-1 alone | GLP-1 + GIP (dual) |
| Visceral fat reduction (DXA) | -27.4% | Greater reduction (meta-analysis ongoing) |
| Nausea/vomiting frequency | About 30–40% | About 35–45% (slightly higher) |
| Reduction in food intake | 16–39% | 20–45% |
| Onset of effect | 8–12 weeks after dose increase | 6–10 weeks after dose increase |
| Muscle loss risk | 25–40% of weight lost | Faster loss means it needs more attention |
Source: SURMOUNT-5 (NEJM 2025) · STEP 1 (NEJM 2021) · 22 RCT 메타분석 2024
A 4-layer defense to steadily maximize Mounjaro's effect
| Layer | What to do | Why |
|---|---|---|
| ① Protein | 1.8–2.2g per kg of body weight (0.2–0.3g more than Wegovy) | Faster weight loss requires a thicker defense line against muscle loss |
| ② Leucine-rich protein | Prioritize whey protein, eggs, chicken breast | Leucine is the switch that turns on the mTOR muscle-synthesis signal |
| ③ Resistance training frequency | 2–3 times a week (one more than Wegovy) | Stronger weight loss needs more frequent muscle stimulation |
| ④ Gradual titration | Hold each dose step for at least 4 weeks before increasing | Eases nausea, muscle loss, and facial sagging all at once |
Source: 리치슬림 4단계 방어막 — 파프짐 룬 시스템 데이터 + SURMOUNT 임상
Quick answer
What matters in a Mounjaro diet is letting your body's structure keep pace with rapid change. Don't rely on appetite suppression alone — only by managing protein, resistance training, sleep, and gut rhythm together will your shape and resilience remain after the weight comes off.
The faster your weekly weight change, the more you should also watch muscle mass, exercise performance, and fatigue.
When the time your stomach is empty grows longer, check whether your water, electrolyte, and protein intake are dropping along with it.
Design exercise to leave a muscle-preservation signal rather than just to burn calories.
Rich Slim focuses on the face, muscle, and recovery routines after weight loss.
How Mounjaro works — what GLP-1 + GIP dual action means
Mounjaro's active ingredient, tirzepatide, is the world's first dual agonist that stimulates both the GLP-1 receptor and the GIP (Glucose-dependent Insulinotropic Polypeptide) receptor at the same time. Whereas Wegovy sends only one signal — GLP-1 — Mounjaro sends two incretin-hormone signals simultaneously. On its own, GIP has weak obesity-treatment effects, but when it works together with GLP-1 it strengthens appetite suppression and improves insulin sensitivity in fat tissue, creating a better environment for fat breakdown. This synergy showed up in the SURMOUNT-5 trial as +5.3%p of additional weight loss versus Wegovy.
Reference · Mounjaro DailyMed FDA / SURMOUNT 임상 시리즈
Why Mounjaro is more powerful than Wegovy
SURMOUNT-5 was a head-to-head trial comparing Mounjaro and Wegovy directly, and at 72 weeks Mounjaro showed -20.2% weight loss versus Wegovy's -14.9%. There are three reasons for the gap — ① the GIP receptor synergizes with GLP-1 in the hypothalamic appetite center, making appetite suppression stronger; ② GIP more effectively promotes the browning of white fat and the activation of brown fat; ③ its insulin-sensitivity improvement is greater, so visceral fat drops faster. In other words, Mounjaro is not 'the same drug made stronger' but 'a new tool that taps an additional signaling pathway.'
Reference · SURMOUNT-5 NEJM 2025 (head-to-head, n=750+)
Side effects of a powerful effect — here's how to manage them
Because Mounjaro's effect is strong, its side effects are also slightly more intense. Nausea (35–45%), vomiting (20–25%), diarrhea (15–20%), and constipation (15%) are the most common, occurring about 5–10%p more often than with Wegovy. But the key is that 'raising the dose slowly resolves most of them.' In the SURMOUNT trials, fewer than 7% actually discontinued the drug because of side effects. Rich Slim's recommended safety protocol — ① hold each dose step for at least 4 weeks (4 weeks minimum, 6–8 weeks to be safe), ② eat slowly, ③ drink 2L+ of water, ④ do only low-intensity exercise during the first 1–2 weeks when nausea is strong, ⑤ adjust the dose while consulting your clinician. This protocol greatly eases the side effects.
Reference · SURMOUNT-1 NEJM 2022 / SURMOUNT-5 NEJM 2025
Muscle loss is faster, so protein matters even more
Losing weight faster also means muscle can be lost faster. Following the book's standard, it's best to aim for 1.5–2.0g of protein per kg for both Wegovy and Mounjaro — 90–120g a day at 60kg, 105–140g at 70kg. And it's not just the 'amount of protein' but 'leucine-rich protein' that matters. Leucine is the switch for the mTOR signal that initiates muscle synthesis, and it is abundant in animal proteins such as whey protein, eggs, chicken breast, and beef. Plant protein alone struggles to deliver the same effect, so topping up with a supplement is practical.
Reference · 22 RCT 메타분석 2024 / West 2012 J Appl Physiol
Exercise frequency — add one more session than Wegovy
The SURMOUNT trials did not require exercise, so they captured the effect of 'the drug alone.' That means adding exercise makes the results even better. Because Mounjaro's weight loss is faster, muscle needs to be stimulated more often. The 2 sessions of resistance training a week recommended for Wegovy users are best increased to 2–3 sessions for Mounjaro users. Build on the four core movements (squat, push-up, mountain climber, burpee) and, where possible, apply the principle of progressive overload by gradually increasing the load. Even in long-accumulated field data, higher exercise frequency clearly correlated with a higher maintenance rate after stopping the drug.
Reference · 현장 데이터 + ACSM 2024 가이드라인
Face and skin care that matters more for Mounjaro users
Because the weight loss is faster, the risk of 'Ozempic face' (facial hollowing) is also slightly higher than with Wegovy. Korean women tend to have a thick dermis and a heavy SMAS, so facial sagging can be more pronounced (Daneshgaran 2024). The prevention is clear — ① deliberately control the rate of loss (within 0.5–1% per week), ② take collagen peptides + vitamin C daily (0.05g of collagen per kg of body weight), ③ maintain a hydration matrix (2L of water + electrolytes), ④ do facial muscle exercises (a beauty cycle using a resistance band), ⑤ apply diligent sun protection. This isn't for cosmetics — it's the work of creating 'the mark of someone who lost weight well.'
Reference · Daneshgaran 2024 (아시아 SMAS) + Korean Society for Aesthetic Plastic Surgery
Rich Slim insight — who Mounjaro shines for most
Mounjaro delivers the greatest value to people with medical obesity at BMI 30 or above, or at BMI 27 or above with comorbidities such as diabetes, hypertension, or dyslipidemia. For those at a normal-to-overweight range who simply want to lose 5–7kg, Wegovy is enough. Mounjaro is a powerful tool, so it is safest and most effective for 'people with a clear medical need.' Decide only after consulting a clinician and reviewing your BMI, comorbidities, current medications, and pregnancy plans. Rich Slim provides the book and tools for free so that Mounjaro users can pursue safe weight loss and maintenance at the same time, using Korean know-how.
Reference · FDA Zepbound Label / 한국비만학회 2024 비만 팩트시트
Speed is an advantage, but without structure it becomes a risk
The faster the weight loss, the more easily the face, muscle, sleep, and gut rhythm can be thrown off. That's why Mounjaro-related management should look at your protein standard, resistance-training frequency, and recovery status together — not just the weight graph.
Your shape is decided by muscle and posture, not weight
Even as weight drops, if the tension in your back, pelvis, hips, and abdomen collapses, you can drift away from the look you want. Rich Slim connects the book and tools so you don't lose posture and resistance training even during weight loss.
The next action lasts only if it isn't complicated
Self-assess your current state, calculate your protein standard, and lock in exercise intensity starting from a low level. Rather than building a perfect routine all at once, the priority is to repeat daily the minimum standard that keeps you from collapsing while you lose weight.
Frequently asked questions
Mounjaro or Wegovy — which is better?
Mounjaro is stronger in effect (-20.2%) than Wegovy (-14.9%). But the larger the effect, the slightly greater the risk of nausea and muscle loss. If you are starting GLP-1 for the first time, or your goal is relatively modest weight loss (within ~10%), we recommend starting safely with Wegovy. For people with medical obesity (BMI 30+) or comorbidities, Mounjaro's stronger effect can deliver greater value. Always consult your clinician.
How much protein should I eat on Mounjaro?
1.8–2.2g per kg of body weight. That is slightly higher than the recommendation for Wegovy (1.5–2g). At 60kg that's 108–132g a day, at 70kg 126–154g. Prioritize 'leucine-rich protein' (whey, eggs, chicken breast) over sheer quantity. Leucine acts as the mTOR switch that turns on the muscle-synthesis signal.
Does raising the dose faster bring faster results?
On the contrary, it only increases side effects. The SURMOUNT trials also raised the dose slowly in 4-week steps, and Rich Slim recommends titrating in 6–8-week steps. Going up slowly eases nausea, vomiting, muscle loss, and facial sagging while still delivering the same final effect. 'Going up slowly is the way to arrive quickly.'
What about alcohol while using Mounjaro?
We don't recommend it. ① Mounjaro slows gastric emptying, so alcohol stays in the stomach longer and raises the risk of nausea and vomiting; ② alcohol interferes with protein synthesis and accelerates muscle loss; and ③ Mounjaro itself slightly raises pancreatitis risk in some people, and alcohol can compound this. If you must drink, limit it to about one glass after a meal, only on days when you've eaten enough protein.
If I stop Mounjaro, will all the weight come back?
Just like Wegovy, yes — if you used only the drug without exercise. The data showing that an average of 70%+ returns within a year of stopping (Jensen 2024) applies to Mounjaro too. The key is to increase your exercise frequency starting 6 months before stopping, restoring your body's endogenous GLP-1 secretion by +37% (Holt 2025). That is your safety belt after stopping the drug.
What should I do if my face hollows out while on Mounjaro?
If it has already begun: ① slow the rate of loss (freeze the dose or step down one level — consult your clinician), ② take 5–10g of collagen peptides daily + 1000mg of vitamin C, ③ maintain a hydration matrix (2L of water + electrolytes such as magnesium and potassium), ④ do 5 minutes of facial muscle resistance exercise daily. Reassess your recovery after 4–8 weeks. In severe cases, we recommend consulting a dermatologist or plastic surgeon.
Is the difference between Mounjaro 15mg and 12.5mg large?
In the SURMOUNT-1 trial, the 15mg arm averaged 22.5% weight loss and the 12.5mg arm 21.0% — a difference of about 1.5%p. Side-effect frequency is slightly higher at 15mg. If you reach your goal at 12.5mg, there's no need to go up to 15mg — talk to your doctor.
What's the difference between Zepbound and Mounjaro?
The active ingredient (tirzepatide) is identical. The US FDA approved Mounjaro for type 2 diabetes and Zepbound for obesity as separate brands. In Korea, Mounjaro is prescribed off-reimbursement for obesity as well. Zepbound has not launched in Korea (as of May 2026).
What dose does Mounjaro start at?
The standard is to start at 2.5mg and step up one level every 4 weeks (2.5 → 5 → 7.5 → 10 → 12.5 → 15). Your doctor adjusts the steps based on side effects, tolerability, and weight change.